Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.

Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

Denmark: A recent study published in the Journal of Diabetes and its Complications has explored the role of kidney fat ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

1 uACR is a sensitive measure of proteinuria across stages of glomerular kidney disease, particularly in hypertension and diabetes, and has been used to assess risk of cardiovascular disease.